TUL Honored as a “Low-Carbon Pioneer Among Listed Chinese Pharmaceutical Companies”

TUL Participates in the 26th Academic Conference of the Chinese Diabetes Society of Chinese Medical Association

TUL’s Cefuroxime Sodium for Injection Passes Generic Drug Consistency Evaluation in Quality and Efficacy

TUL Participates in the 2024 Diabetes Frontier Academic Forum Organized by the Diabetes Professional Committee of Chinese Research Hospital Association 

The United Bio-Technology (Hengqin) Co., Ltd. Recognized as a Benchmark Project in the Biopharmaceutical and Comprehensive Health Industry of the Guangdong-Macao In-Depth Cooperation Zone in Hengqin

TUL Recognized in Four Lists including “Top 100 Hong Kong Stocks”, Showcasing Its Outstanding Strength 

The United Bio-Technology (Hengqin) Co., Ltd. Recognized as a Benchmark Project in the Biopharmaceutical and Comprehensive Health Industry of the Guangdong-Macao In-Depth Cooperation Zone in Hengqin 

TUL Selected as a “Manufacturing Single Champion Enterprise of Inner Mongolia Autonomous Region” 

TUL’s Cefotaxime for Injection (1.0g) Passes Generic Drug Consistency Evaluation in Quality and Efficacy